BOUNDLESS BIO, INC. (BOLD) Operating income 2023–2025
BOUNDLESS BIO, INC. (BOLD) annual operating income history from SEC filings — each fiscal year as reported.
-$63.6MFY2025 · since FY2023: -$54.8M → -$63.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$63.6M | +13.3% |
| FY2024 | -$73.3M | -33.7% |
| FY2023 | -$54.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLD financial trends
BOLD RevenueBOLD Net incomeBOLD Net marginBOLD Gross profitBOLD Gross marginBOLD Operating marginBOLD Operating cash flowBOLD Free cash flowBOLD Capital expendituresBOLD Return on equityBOLD Stock buybacksBOLD Dividends paidBOLD Total assetsBOLD Total liabilitiesBOLD Shareholders’ equityBOLD overview →